These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 8875996)
1. Physical mapping of the DDX1 gene to 340 kb 5' of MYCN. Kuroda H; White PS; Sulman EP; Manohar CF; Reiter JL; Cohn SL; Brodeur GM Oncogene; 1996 Oct; 13(7):1561-5. PubMed ID: 8875996 [TBL] [Abstract][Full Text] [Related]
2. Amplification of a DEAD box gene (DDX1) with the MYCN gene in neuroblastomas as a result of cosegregation of sequences flanking the MYCN locus. Noguchi T; Akiyama K; Yokoyama M; Kanda N; Matsunaga T; Nishi Y Genes Chromosomes Cancer; 1996 Feb; 15(2):129-33. PubMed ID: 8834177 [TBL] [Abstract][Full Text] [Related]
3. The DDX1 gene maps within 400 kbp 5' to MYCN and is frequently coamplified in human neuroblastoma. Amler LC; Schürmann J; Schwab M Genes Chromosomes Cancer; 1996 Feb; 15(2):134-7. PubMed ID: 8834178 [TBL] [Abstract][Full Text] [Related]
4. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma. Squire JA; Thorner PS; Weitzman S; Maggi JD; Dirks P; Doyle J; Hale M; Godbout R Oncogene; 1995 Apr; 10(7):1417-22. PubMed ID: 7731693 [TBL] [Abstract][Full Text] [Related]
5. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group. George RE; Kenyon RM; McGuckin AG; Malcolm AJ; Pearson AD; Lunec J Oncogene; 1996 Apr; 12(7):1583-7. PubMed ID: 8622876 [TBL] [Abstract][Full Text] [Related]
6. Amplification of Mycn, Ddx1, Rrm2, and Odc1 in rat uterine endometrial carcinomas. Karlsson A ; Helou K; Walentinsson A; Hedrich HJ; Szpirer C; Levan G Genes Chromosomes Cancer; 2001 Aug; 31(4):345-56. PubMed ID: 11433525 [TBL] [Abstract][Full Text] [Related]
7. Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma. Manohar CF; Salwen HR; Brodeur GM; Cohn SL Genes Chromosomes Cancer; 1995 Nov; 14(3):196-203. PubMed ID: 8589036 [TBL] [Abstract][Full Text] [Related]
8. Coamplification of DDX1 correlates with an improved survival probability in children with MYCN-amplified human neuroblastoma. Weber A; Imisch P; Bergmann E; Christiansen H J Clin Oncol; 2004 Jul; 22(13):2681-90. PubMed ID: 15226335 [TBL] [Abstract][Full Text] [Related]
9. Relational mapping of MYCN and DDXI in band 2p24 and analysis of amplicon arrays in double minute chromosomes and homogeneously staining regions by use of free chromatin FISH. Pandita A; Godbout R; Zielenska M; Thorner P; Bayani J; Squire JA Genes Chromosomes Cancer; 1997 Nov; 20(3):243-52. PubMed ID: 9365831 [TBL] [Abstract][Full Text] [Related]
10. Two-dimensional DNA electrophoresis identifies novel CpG islands frequently coamplified with MYCN in neuroblastoma. Wimmer K; Zhu XX; Lamb BJ; Kuick R; Ambros P; Kovar H; Thoraval D; Elkahloun A; Meltzer P; Hanash SM Med Pediatr Oncol; 2001 Jan; 36(1):75-9. PubMed ID: 11464910 [TBL] [Abstract][Full Text] [Related]
12. Relationship of DDX1 and NAG gene amplification/overexpression to the prognosis of patients with MYCN-amplified neuroblastoma. Kaneko S; Ohira M; Nakamura Y; Isogai E; Nakagawara A; Kaneko M J Cancer Res Clin Oncol; 2007 Mar; 133(3):185-92. PubMed ID: 17028906 [TBL] [Abstract][Full Text] [Related]
13. An integrated 5-Mb physical, genetic, and radiation hybrid map of a 1p36.1 region implicated in neuroblastoma pathogenesis. Spieker N; Beitsma M; van Sluis P; Roobeek I; den Dunnen JT; Speleman F; Caron H; Versteeg R Genes Chromosomes Cancer; 2000 Feb; 27(2):143-52. PubMed ID: 10612802 [TBL] [Abstract][Full Text] [Related]
14. Analysis of candidate gene co-amplification with MYCN in neuroblastoma. George RE; Kenyon R; McGuckin AG; Kohl N; Kogner P; Christiansen H; Pearson AD; Lunec J Eur J Cancer; 1997 Oct; 33(12):2037-42. PubMed ID: 9516849 [TBL] [Abstract][Full Text] [Related]
15. High-resolution mapping of a 130-kb core region of the MYCN amplicon in neuroblastomas. Reiter JL; Brodeur GM Genomics; 1996 Feb; 32(1):97-103. PubMed ID: 8786126 [TBL] [Abstract][Full Text] [Related]
16. Concomitant DDX1 and MYCN gain in neuroblastoma. Defferrari R; Tonini GP; Conte M; Papio F; Sementa AR; Valent A; Schena F; Perri P; Mazzocco K Cancer Lett; 2007 Oct; 256(1):56-63. PubMed ID: 17611020 [TBL] [Abstract][Full Text] [Related]
17. Expression of two dead box genes (DDX1 and DDX6) is independent of that of MYCN in human neuroblastoma cell lines. Akiyama K; Akao Y; Yokoyama M; Nakagawa Y; Noguchi T; Yagi K; Nishi Y Biochem Mol Biol Int; 1999 Apr; 47(4):563-8. PubMed ID: 10319407 [TBL] [Abstract][Full Text] [Related]
18. High-resolution mapping of the N-myc amplicon core domain in neuroblastomas. Hiemstra JL; Schneider SS; Brodeur GM Prog Clin Biol Res; 1994; 385():51-7. PubMed ID: 7972237 [TBL] [Abstract][Full Text] [Related]
19. MYCN amplification and 17q in neuroblastoma: evidence for structural association. O'Neill S; Ekstrom L; Lastowska M; Roberts P; Brodeur GM; Kees UR; Schwab M; Bown N Genes Chromosomes Cancer; 2001 Jan; 30(1):87-90. PubMed ID: 11107180 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of a DEAD box protein (DDX1) in neuroblastoma and retinoblastoma cell lines. Godbout R; Packer M; Bie W J Biol Chem; 1998 Aug; 273(33):21161-8. PubMed ID: 9694872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]